Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cerebrospinal Fluid01:21

Cerebrospinal Fluid

8.7K
Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
8.7K
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

4
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
4
Proteomics01:33

Proteomics

10.3K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
10.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional patterns of grey matter volume decline in relapsing-remitting multiple sclerosis relative to healthy ageing.

NeuroImage·2026
Same author

Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

The New England journal of medicine·2026
Same author

Alpha-linolenic acid associations with disability and brain volume in multiple sclerosis: a brief replication report.

Frontiers in neurology·2026
Same author

Cost-effectiveness of treatment sequences following first-line rituximab in relapsing-remitting multiple sclerosis: a Norwegian microsimulation study.

Frontiers in neurology·2026
Same author

Managing Relapsing Multiple Sclerosis Across the Lifespan: A Narrative Review with Expert Opinion from Norway.

Neurology and therapy·2026
Same author

Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study.

BMJ neurology open·2026

Related Experiment Video

Updated: Apr 19, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

8.5K

Cerebrospinal fluid proteomics in multiple sclerosis.

Ann C Kroksveen1, Jill A Opsahl1, Astrid Guldbrandsen2

  • 1Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Postbox 7804, N-5009 Bergen, Norway; The KG Jebsen Centre for MS-Research, Department of Clinical Medicine, University of Bergen, Postbox 7804, N-5021 Bergen, Norway.

Biochimica Et Biophysica Acta
|December 21, 2014
PubMed
Summary
This summary is machine-generated.

Researchers are exploring cerebrospinal fluid (CSF) proteomics to find biomarkers for multiple sclerosis (MS). This approach aids in early diagnosis, understanding disease mechanisms, and identifying new treatment targets for MS.

Keywords:
BiomarkerCerebrospinal fluidMultiple sclerosisProteomics

More Related Videos

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid
10:23

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid

Published on: December 4, 2017

9.5K
Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
08:23

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Published on: November 29, 2019

12.1K

Related Experiment Videos

Last Updated: Apr 19, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

8.5K
Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid
10:23

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid

Published on: December 4, 2017

9.5K
Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
08:23

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Published on: November 29, 2019

12.1K

Area of Science:

  • Neuroscience
  • Neurology
  • Proteomics

Background:

  • Multiple sclerosis (MS) is a chronic, inflammatory central nervous system disease affecting millions globally.
  • Current MS treatments are more effective when initiated early, but diagnosis and prognosis remain challenging.
  • Novel biomarkers are crucial for understanding MS mechanisms, enabling early diagnosis, predicting progression, and identifying therapeutic targets.

Purpose of the Study:

  • To review the current state of cerebrospinal fluid (CSF) proteomics in multiple sclerosis (MS).
  • To discuss recent findings in CSF proteome analysis for MS over the past five years.
  • To highlight the potential of CSF proteomics in advancing MS research and clinical practice.

Main Methods:

  • Quantitative proteomics techniques applied to cerebrospinal fluid (CSF) samples.
  • Comparative analysis of CSF proteomes between MS patients and healthy controls.
  • Examination of proteomic differences within subgroups of MS patients.

Main Results:

  • Proteomics studies have identified potential biomarker candidates in the CSF of MS patients.
  • Analysis reveals distinct proteomic profiles associated with MS, aiding in disease characterization.
  • Recent advancements have refined methodologies for CSF proteome analysis in MS.

Conclusions:

  • Cerebrospinal fluid (CSF) proteomics is a promising strategy for discovering MS biomarkers.
  • This approach can significantly contribute to earlier diagnosis, personalized treatment, and a better understanding of MS pathophysiology.
  • Continued research in neuroproteomics is vital for improving outcomes for individuals with multiple sclerosis.